Part 5 Flashcards
What are 4 measures of the level of bioequivalence
-pharmaceutical equivalents
-pharmaceutical alternatives
-biological equivalents (bioequivalents)
-therapeutic equivalents
What are pharmaceutical equivalents
Drug products are considered to be equivalents if they contain the same active ingredient and are identical in strength or concentrations, dosage form, and route of administration
What are pharmaceutical alternatives
pharmaceutical alternatives are those drug products that contain the same therapeutic components, but are different salts, esters, or complexes of that moeity, OR are different dosages or strengths
What are biological equivalents (bioequivalents)
bioequivalents ARE PHARMACEUTICAL EQUIVALENTS that exhibit comparable bioavailability when studied under similar experimental conditions
what are therapeutic equivalents
therapeutic equivalents are pharmaceutical equivalents that can be expected to have the same clinical effect when administered to patients under the conditions specified in the label
Bioequivalence means equivalence of bioavailability of two or more ____ (or _____) of the same drug.
If the products have similar bioavailability when tested under similar conditions, they are considered ________
bioequivalence means equivalence of bioavailability of 2 or more PRODUCTS (or dosage forms) of the SAME DRUG
bioequivalent
What is evaluated to determine if 2 different products or dosage forms of the same drug are bioequivalent?
the parameters of bioavailability are evaluated for bioequivalence
(Cmax, Tmax, and AUC)
100mg Ibuprofen and 100mg salt ibuprofen – what is the term for these
these are pharmaceutical alternatives because they contain the same therapeutic moiety but are different salts of that moeity
Explain the starting steps of conducting a bioequivalence study
-a panel of 24 or more subjects is used
-usually HEALTHY subjects are selected
-subjects should be a similar age and weight
-all subjects are evaluated by a physician to assure they are suitable for participation in the study
Is a bioequivalence study blinded?
yes —- it is double blinded.
Neither the researcher nor the subject knows what product is being given to the subject
Explain how a double blinded bioequivalence study is conducted
-the subjects are divided into 2 groups. All subjects receive both products, but one product at a time.
-blood samples are collected at predetermined times and the concentration of drug in each blood sample is determined.
- a washout period is used (baseline) to assure that the 1st product is virtually eliminated from the body before the 2nd product is administered
(DOUBLE BLIND)
Explain how the results of a bioequivalence study are analyzed
-the data is analyzed by an IMPARTIAL researcher or agency to avoid bias
-Average plasma-drug concentration vs time for each product is plotted
-Cmax, Tmax, and AUC for both products is determined.
-these 3 parameters are compared to determine bioequivalence
What are 2 ways to control the plasma profile
-formulation
-administration (dosage form?)
Oral
mouth
Peroral
gastrointestinal tract via mouth
sublingual
under the tongue
parenteral
other than the gastrointestinal tract (by injection)
intravenous
vein
Intra-arterial
artery
intracardiac
heart
intraspinal/intrathecal
spine
intraosseous
bone
intra-articular
joint